Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JHG002 Therapy for Chronic Low Back Pain
NCT07304076Recruiting
- Sponsor
- Jaseng Medical Foundation
- Start
- Dec 2025
- Primary completion
- Nov 2029
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised trial of JHG002 in chronic low back pain (CLBP) (2 arms), sponsored by Jaseng Medical Foundation. Primary endpoint: Change in low back pain intensity at 25 weeks. Started Dec 2025; status: recruiting.
02
Drugs
JHG002
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT07304076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07304076.